Recursion Pharmaceuticals, Inc. (RXRX) is a pioneering clinical-stage biotechnology firm based in Salt Lake City, Utah, focused on transforming drug discovery through a unique integration of advanced technologies in biology, chemistry, and data science. Leveraging its proprietary platform that combines high-throughput automation with sophisticated deep learning algorithms, Recursion seeks to unravel intricate biological systems and accelerate the development of groundbreaking therapies for various diseases. As a significant entity within the biopharmaceutical landscape, the company is dedicated to improving the efficiency of drug discovery, with the goal of delivering innovative treatments to market more rapidly and effectively. Show more

Location: 41 SOUTH RIO GRANDE STREET, SALT LAKE CITY, UT, UNITED STATES, 84101, Salt Lake City, UT, 84101, USA | Website: https://www.recursion.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

2.184B

52 Wk Range

$3.79 - $12.36

Previous Close

$4.19

Open

$4.12

Volume

17,329,671

Day Range

$4.08 - $4.26

Enterprise Value

1.607B

Cash

659.8M

Avg Qtr Burn

-117.4M

Insider Ownership

4.00%

Institutional Own.

61.69%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
REC-4881 Details Cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-3964 Details Clostridium difficile Colitis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-4881 Details Familial Adenomatous Polyposis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-1245 Details Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-4539 Details Small cell lung cancer, Cancer	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-3565 Details R/R B-cell Lymphoma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-617 Details Solid tumor/s, Cancer	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-7735 (PI3K Alpha Inhibitor) Details Breast And Other Solid Tumors Harboring PI3K Alpha H1047R Mutation	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-102 Details Hypophosphatasia (HPP)	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-2282 Details Neurofibromatosis Type 2-mutated meningiomas	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-3599 Details GM2 gangliosidosis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REC-994 Details Cerebral cavernous malformation	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.